Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues. 2009

Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
Photochemistry Department, National Research Center, El Dokki, Cairo, Egypt.

A number of new 5-[(naphthalen-5-yloxy)methyl]-1,3,4-oxadiazole derivatives, 2-5 and 8-11, were synthesized. The 2-{5-[(naphthalen-5-yloxy)methyl]-1,3,4-oxadiazol-2-ylthio}acetohydrazones 6a and 6b were synthesized by the reaction of the hydrazide 4 with the corresponding monosaccharides. Cyclization of the sugar hydrazones 6a and 6b with acetic anhydride afforded the substituted oxadiazoline derivatives 7a and 7b. The synthesized compounds were evaluated for their antiviral activity against, the human immunodeficiency virus (HIV-1) and some of these compounds showed moderate to high antiviral activity.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
December 2018, Molecules (Basel, Switzerland),
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
May 2018, European journal of medicinal chemistry,
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
November 2020, International journal of molecular sciences,
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
December 2023, ACS omega,
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
August 2010, Nucleosides, nucleotides & nucleic acids,
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
February 2019, Chemistry & biodiversity,
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
June 2021, International journal of molecular sciences,
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
January 2014, Acta poloniae pharmaceutica,
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
September 2010, Nucleosides, nucleotides & nucleic acids,
Wael A El-Sayed, and Farag A El-Essawy, and Omar M Ali, and Barsis S Nasr, and Mohamed M Abdalla, and Adel A-H Abdel-Rahman
December 2020, BMC chemistry,
Copied contents to your clipboard!